Flagship Pioneering Inc. - 10%+ Owner at Omega Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
OMGA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Flagship Pioneering Inc. since 11/21/2023

Holdings reported by Flagship Pioneering Inc. for Omega Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8.62M $68.9M $8.00 Feb 27, 2023 By Flagship Pioneering Fund VI, L.P.
Common Stock 7.51M $60.1M $8.00 Feb 27, 2023 By Flagship Pioneering Special Opportunities Fund II, L.P.
Common Stock 5.9M $47.2M $8.00 Feb 27, 2023 By Flagship Ventures Fund V, L.P.
Common Stock 2.2M $17.6M $8.00 Feb 27, 2023 By Flagship VentureLabs V, LLC
Common Stock 1.62M $12.9M $8.00 Feb 27, 2023 By FPN, L.P.
Common Stock 1.62M $12.9M $8.00 Aug 3, 2021 Indirect
Common Stock 1.33M $10.6M $8.00 Feb 27, 2023 By Flagship Pioneering Fund VII, L.P.
Common Stock 1.09M $8.71M $8.00 Feb 27, 2023 By Flagship V VentureLabs Rx Fund, L.P.
Common Stock 971K $7.76M $8.00 Feb 27, 2023 By Nutritional Health LTP Fund, L.P.
Series A Convertible Preferred Stock 0 Aug 3, 2021 Indirect Common Stock
Series B Convertible Preferred Stock 0 Aug 3, 2021 Indirect Common Stock
Series C Convertible Preferred Stock 0 Aug 3, 2021 Indirect Common Stock

Transactions reported by Flagship Pioneering Inc. for Omega Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.